Indole derivatives as CRTH2 receptor antagonists

Details for Australian Patent Application No. 2006281937 (hide)

Owner Merck Frosst Canada Ltd

Inventors Wang, Zhaoyin

Agent Spruson & Ferguson

Pub. Number AU-B-2006281937

PCT Pub. Number WO2007/019675

Priority 60/708,043 12.08.05 US

Filing date 7 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 17 November 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/019675 Priority application(s): WO2007/019675

17 November 2011 Application Accepted

  Published as AU-B-2006281937

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281941-Wireless communications device including a joint space-time optimum filter (JSTOF) using Cholesky and eigenvalue decompositions

2006281930-Joint space-time optimum filters (JSTOF) for interference cancellation